Why Complete Dose Availability Matters for Your Treatment Success
Wegovy Doses vs Mounjaro: Complete Treatment Range Explained
When comparing Wegovy doses vs Mounjaro, understanding the complete dose escalation journey is crucial for long-term success. Wegovy requires five distinct doses: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards. Mounjaro follows a similar escalation pattern with its own dose strengths. EverydayMeds stocks every single dose of both treatments, eliminating the frustration of switching pharmacies mid-treatment when many suppliers run short of specific strengths.
Having access to all doses means your treatment continuity is protected throughout the entire 16-week escalation period and beyond into maintenance. Many patients find their progress disrupted when pharmacies cannot supply the next required dose, potentially forcing treatment interruptions that can affect results. Our comprehensive stock holding across both Wegovy and Mounjaro ensures seamless progression through your prescribed treatment pathway, whether your clinician recommends the GLP-1-only approach of Wegovy or the dual-action mechanism of Mounjaro.
Pricing Structure for Wegovy Doses vs Mounjaro: Complete Cost Breakdown
Understanding the full financial commitment when comparing Wegovy doses vs Mounjaro helps you plan your weight management investment effectively. Wegovy single pens range from £79.99 for the 0.25mg starter dose through to £209.99 for the 2.4mg maintenance dose, with new customers applying discount code FIRST40 at checkout. Our Getting Started bundles, such as the Intro Duo (0.25mg & 0.5mg) at £169.99, provide the first two months of treatment in one convenient order. The Advance Duo (1mg & 1.7mg) costs £269.99, whilst our Elevate Duo (1.7mg & 2.4mg) is priced at £369.99.
For patients requiring extended time at specific doses, our Stay Steady bundles offer excellent value—the Consistency 2.4mg bundle provides two maintenance pens for £419.99. Three-pen bundles cater to longer treatment periods, with the Intro Trio covering your first three months at £299.99, and the Ultimate Stability Trio providing three months of 2.4mg maintenance dosing for £649.99. Returning customers benefit from discount code DOSE25, making ongoing treatment more affordable whilst ensuring continuous access to every required dose strength.
Clinical Evidence Supporting Wegovy Doses vs Mounjaro Treatment Approaches
The clinical evidence supporting both treatments demonstrates their effectiveness when used alongside a reduced-calorie diet and increased physical activity. In the landmark STEP trials, patients taking Wegovy achieved an average weight reduction of approximately 15% at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The systematic dose escalation protocol used in these trials—from 0.25mg through to 2.4mg—forms the basis of current prescribing guidelines and emphasises why having access to every dose is essential.
Mounjaro's clinical trials demonstrate the effectiveness of its dual GIP and GLP-1 receptor agonist approach, though direct head-to-head comparisons between the two treatments aren't available due to different trial designs and populations. Both medications have received MHRA approval for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities, and both require prescription-only medicine protocols with appropriate clinical oversight throughout treatment.
How Wegovy Works: GLP-1 Mechanism in Doses Comparison
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones responsible for blood sugar regulation and appetite control. When administered via the once-weekly FlexTouch pen, semaglutide binds to GLP-1 receptors in your brain's appetite centres, promoting feelings of fullness and reducing food cravings between meals. The gradual dose escalation—from 0.25mg starter through to 2.4mg maintenance—allows your body to adapt to the medication whilst minimising potential side effects. This systematic approach means each dose builds upon the previous level, creating sustainable appetite regulation that supports long-term weight management goals. The 2.4mg maintenance dose represents the optimal therapeutic level for most patients, providing consistent appetite suppression whilst maintaining tolerability throughout extended treatment periods.
Streamlined Ordering Process for All Wegovy and Mounjaro Doses
Accessing any dose of Wegovy or Mounjaro through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, designed to capture all relevant medical history and current medications. Our qualified prescribers, working under GPhC registration #9012878, review each assessment thoroughly, with standard reviews completed within 3 working days or express 24-hour options available for urgent requirements. Once your prescription is approved, your chosen dose ships via next-day delivery using temperature-controlled cold-chain logistics to ensure medication integrity. Whether you're ordering individual pens, convenient dose-progression bundles, or maintenance supplies, our streamlined process ensures reliable access to your prescribed treatment without unnecessary delays or complications. Patient safety remains paramount throughout, with ongoing clinical monitoring and support available for any questions about your prescribed dosing schedule.
Storage and Practical Considerations: Wegovy vs Mounjaro Doses
Storage requirements represent a practical advantage when comparing Wegovy doses vs Mounjaro, particularly for patients who travel frequently or prefer medication flexibility. Wegovy pens maintain stability for up to 6 weeks at room temperature (below 30°C) once removed from refrigerated storage, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy particularly suitable for business travellers, holiday periods, or patients who prefer not to transport refrigerated medications. Both medications require initial storage at 2-8°C until first use, and both utilise pre-filled pen devices for convenient once-weekly administration. The FlexTouch pen system used for Wegovy provides dose confirmation and easy injection technique, whilst maintaining accurate dosing throughout the escalation schedule from 0.25mg starter doses through to 2.4mg maintenance levels.
Complete Dose Journey Planning: Wegovy Escalation vs Mounjaro Titration
Planning your complete dose journey when weighing Wegovy doses vs Mounjaro requires understanding each medication's escalation timeline and your pharmacy's ability to supply every required strength. Wegovy's structured 16-week titration—spending 4 weeks each at 0.25mg, 0.5mg, 1mg, and 1.7mg before reaching 2.4mg maintenance—cannot be rushed or modified without clinical guidance. Stock availability becomes crucial during this period, as missing even one dose strength can disrupt your carefully managed progression and potentially compromise treatment outcomes.
EverydayMeds' comprehensive stock holding across all Wegovy and Mounjaro doses eliminates supply uncertainty, allowing you to focus on your health goals rather than pharmacy logistics. Our dose-progression bundles anticipate your needs, whilst individual pen availability ensures flexibility for patients requiring extended time at specific strengths. Whether your clinician recommends Wegovy's proven GLP-1 approach or Mounjaro's innovative dual-receptor mechanism, having access to every dose throughout your journey provides the treatment continuity essential for optimal results.
Secure Your Complete Treatment Journey Today
Both Wegovy and Mounjaro are available from EverydayMeds with complete dose range coverage, ensuring your weight management journey never faces supply interruptions. Our competitive pricing, from Wegovy 0.25mg at £79.99 through to maintenance doses, combined with convenient bundle options and discount codes FIRST40 (new customers) or DOSE25 (returning patients), makes comprehensive treatment accessible and affordable. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment today, with prescriber review, MHRA-approved medications, and next-day delivery ensuring rapid treatment commencement. As a GPhC-registered pharmacy (#9012878), we provide ongoing clinical support throughout your prescribed treatment, whether you choose Wegovy's established semaglutide therapy or Mounjaro's dual-action approach. Your prescriber can help determine which prescription-only medicine best suits your individual circumstances and weight management goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
